filmov
tv
From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17
Показать описание
Dr. Rashmi Kanagal-Shamanna shows how MDS, or myelodysplastic syndromes, can progress to AML (acute myeloid leukemia) during this recorded webinar.
Originally broadcast on October 10, 2017
Originally broadcast on October 10, 2017
1:40:23
From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17
0:34:15
From MDS to AML: What Every Patient Needs to Know 11/28/17
1:13:29
Understanding Higher Risk MDS and Transtion to AML
0:01:16
Developing an understanding of disease progression in MDS and AML
0:06:35
Understanding AML
0:50:26
MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS Patients
0:06:33
Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
0:02:38
Managing the progression of MDS to AML
0:13:47
Myelodysplastic Syndrome (MDS) - a precursor to Acute Myeloid Leukemia (AML) ?! - Hematology Series
0:33:29
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
1:02:31
Understanding QoL (Quality of life) in High-Risk MDS & AML
0:45:46
Acute Myelogenous Leukemia (AML)
0:20:33
From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)
0:05:38
Understanding AML-MRC and tAML
0:33:47
My approach to MDS management
0:07:26
MDS: Understanding Disease Characteristics and Progression
0:18:41
2022 Scientific Symposium Highlights for Patients: MDS and Secondary AML Pathophysiology
0:00:48
How do you distinguish between a diagnosis of MDS and AML? #AML
1:00:20
Advances in Treating High Risk MDS and AML
0:17:53
Biology of AML Developing from MDS vs. de Novo AML, and New Targets for Therapy
0:22:08
The Origin of Relapses MDS/AML - L Shlush
0:55:36
Short Telomere Syndrome Implications for MDS and AML Patients
0:01:55
How do you distinguish MDS from AML and why is it sometimes difficult?
0:16:23
Venetoclax in Higher-Risk MDS/AML
Комментарии